A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L

West Japan Oncology Group

doi:10.1093/annonc/mdu541

A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L

West Japan Oncology Group

Department of Respirology

Research output: Contribution to journal › Article › peer-review

77 Citations (Scopus)

Abstract

In this largest phase II trial with advanced thymic carcinoma (TC), carboplatin and paclitaxel (CbP) showed promising efficacy in advanced TC when compared with anthracycline-based chemotherapy, which is the current standard treatment of TC. Our results established that CbP, one of the standard treatments for non-small-cell lung cancer, might be an option as a chemotherapy regimen for TC.

Original language	English
Pages (from-to)	363-368
Number of pages	6
Journal	Annals of Oncology
Volume	26
Issue number	2
DOIs	https://doi.org/10.1093/annonc/mdu541
Publication status	Published - Feb 1 2015

All Science Journal Classification (ASJC) codes

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdu541

Cite this

@article{d03ad3fe449943deb99309c37da88978,

title = "A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L",

abstract = "In this largest phase II trial with advanced thymic carcinoma (TC), carboplatin and paclitaxel (CbP) showed promising efficacy in advanced TC when compared with anthracycline-based chemotherapy, which is the current standard treatment of TC. Our results established that CbP, one of the standard treatments for non-small-cell lung cancer, might be an option as a chemotherapy regimen for TC.",

author = "{West Japan Oncology Group} and F. Hirai and T. Yamanaka and K. Taguchi and H. Daga and A. Ono and K. Tanaka and Y. Kogure and J. Shimizu and T. Kimura and J. Fukuoka and Y. Iwamoto and H. Sasaki and K. Takeda and Takashi Seto and Y. Ichinose and K. Nakagawa and Y. Nakanishi",

year = "2015",

month = feb,

day = "1",

doi = "10.1093/annonc/mdu541",

language = "English",

volume = "26",

pages = "363--368",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma

T2 - WJOG4207L

AU - West Japan Oncology Group

AU - Hirai, F.

AU - Yamanaka, T.

AU - Taguchi, K.

AU - Daga, H.

AU - Ono, A.

AU - Tanaka, K.

AU - Kogure, Y.

AU - Shimizu, J.

AU - Kimura, T.

AU - Fukuoka, J.

AU - Iwamoto, Y.

AU - Sasaki, H.

AU - Takeda, K.

AU - Seto, Takashi

AU - Ichinose, Y.

AU - Nakagawa, K.

AU - Nakanishi, Y.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - In this largest phase II trial with advanced thymic carcinoma (TC), carboplatin and paclitaxel (CbP) showed promising efficacy in advanced TC when compared with anthracycline-based chemotherapy, which is the current standard treatment of TC. Our results established that CbP, one of the standard treatments for non-small-cell lung cancer, might be an option as a chemotherapy regimen for TC.

AB - In this largest phase II trial with advanced thymic carcinoma (TC), carboplatin and paclitaxel (CbP) showed promising efficacy in advanced TC when compared with anthracycline-based chemotherapy, which is the current standard treatment of TC. Our results established that CbP, one of the standard treatments for non-small-cell lung cancer, might be an option as a chemotherapy regimen for TC.

UR - http://www.scopus.com/inward/record.url?scp=84925300119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925300119&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdu541

DO - 10.1093/annonc/mdu541

M3 - Article

C2 - 25403584

AN - SCOPUS:84925300119

SN - 0923-7534

VL - 26

SP - 363

EP - 368

JO - Annals of Oncology

JF - Annals of Oncology

IS - 2

ER -

A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this